Utilization of hyperbaric oxygen therapy and induced hypothermia after hydrogen sulfide exposure
- PMID: 22004989
- PMCID: PMC3913469
- DOI: 10.4187/respcare.01038
Utilization of hyperbaric oxygen therapy and induced hypothermia after hydrogen sulfide exposure
Abstract
Hydrogen sulfide is a toxic gas produced as a by-product of organic waste and many industrial processes. Hydrogen sulfide exposure symptoms may vary from mild (dizziness, headaches, nausea) to severe lactic acidosis via its inhibition of oxidative phosphorylation, leading to cardiac arrhythmias and death. Treatment is generally supportive. We report the case of a patient presenting with cardiac arrest secondary to hydrogen sulfide exposure treated with both hyperbaric oxygen therapy and therapeutic hypothermia to achieve full neurologic recovery.
Conflict of interest statement
Conflict of Interest Statement:
Mir Asif has no conflicts of interest to declare.
Matthew Exline has no conflicts of interest to declare.
References
-
- Woodall GM, Smith RL, Granville GC. Proceedings of the Hydrogen Sulfide Health Research and Risk Assessment Symposium October 31-November 2, 2000. Inhal Toxicol. 2005;17(11):593–639. - PubMed
-
- Bronstein AC, Spyker DA, Cantilena LR, Jr, Green JL, Rumack BH, Heard SE. 2007 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila) 2008;46(10):927–1057. - PubMed
-
- Smilkstein MJ, Bronstein AC, Pickett HM, Rumack BH. Hyperbaric oxygen therapy for severe hydrogen sulfide poisoning. J Emerg Med. 1985;3(1):27–30. - PubMed
-
- Clifton GL. Hypothermia and hyperbaric oxygen as treatment modalities for severe head injury. New Horiz. 1995;3(3):474–478. - PubMed
-
- Hendrickson RG, Chang A, Hamilton RJ. Co-worker fatalities from hydrogen sulfide. Am J Ind Med. 2004;45(4):346–350. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
